Hes also had a history of chronic lower gastrointestinal (GI) tract issues
However, the molecular mechanism of cell aging, especially stress-induced premature aging in liver fibrosis, is still poorly understood
In the context of SUD, such mechanisms could plausibly reduce craving and compulsive drug-seeking, aligning with preclinical work showing attenuation of substance-related reinforcement and with emerging clinical data suggesting reduced alcohol-related outcomes among GLP-1RA users (18, 35)
The clinical data for orforglipron is promising, and Eli Lilly plans to submit it for FDA approval as a weight loss treatment in 2025 (and for type 2 diabetes in 2026)
Over a month, you and your provider can review those to see if the injection is helping
You dont want your anti-inflammatory supplements to work so well that they block healthy, adaptive inflammation too